Scott D. Solomon, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bayer(MODEST), Amgen(MODEST), Novartis(MODEST), Alnylam(MODEST), Astra Zeneca(MODEST), BMS(MODEST), Cytokinetics(MODEST), Gilead Sciences, Inc. (MODEST), Myokardia(MODEST), Theracos(SIGNIFICANT), Corvia(MODEST), Merck(MODEST), Roche(SIGNIFICANT), Quantum Genomics(MODEST), Cardurion(MODEST), Janssen Pharmaceuticals, Inc(MODEST), Cardiac Dimensions(SIGNIFICANT), Abiome(MODEST), Takeda(MODEST), GSK(MODEST), Cardior(MODEST), Ironwood(MODEST), Tenaya(MODEST) RESEARCH/RESEARCH GRANTS: Amgen(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Sanofi(SIGNIFICANT), Novartis(SIGNIFICANT), Alnylam(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), BMS(SIGNIFICANT), Cytokinetics(SIGNIFICANT), Eidos(SIGNIFICANT), Gilead(SIGNIFICANT), Ionis(SIGNIFICANT), Myokardia(SIGNIFICANT), Theracos(SIGNIFICANT), TEVA/Mesoblast(SIGNIFICANT), Celledon(SIGNIFICANT), Mesoblast(SIGNIFICANT)

View Full Disclosure